A multidisciplinary group of research institutions and private companies to bring the next generation insulin delivery system to life: the Prisma Consortium’s expertise covers the full research and market development value chain of the project. DTU, WIS and D1 were partners in the previous FET BioWings project, and UPV has been added to develop and validate the micropump in a relevant environment.
DTU is the Technical University of Denmark. With its international elite research and study programmes, its large experimental facilities and interdisciplinary research environments, DTU is working towards the resolution of global challenges formulated in the UN’s 17 Sustainable Development Goals.
The Weizmann Institute of Science (WIS) is one of the world’s leading multidisciplinary research centers with 2500 scientists (220 research groups), postdoctoral fellows, Ph.D. and M.Sc. students, and scientific, technical and administrative staff. WIS has one of the highest rankings in publication impact per scientist; and holds one of the leading places in the world in commercialization of intellectual property.
Day One is an Innovation Studio where research is transformed into products capable of generating economic and social impact. Day One teams up with researchers and inventors to transform disruptive technologies into game changing solutions and start-ups, through product development, venture building and fundraising.
Instituto Universitario de Automática e Informática Industrial of UPV is a multidisciplinary research institution including a patient-centred innovation environment of new health technologies and products. They have15 years of expertise in artificial pancreas development, among different areas, such as robotics, industrial computing, process control, computer vision and graphics and multimedia computing.